Free Trial

Sana Biotechnology (SANA) Short Interest Ratio & Short Volume

Sana Biotechnology logo
$2.68 -0.09 (-3.25%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$2.70 +0.02 (+0.75%)
As of 06/12/2026 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sana Biotechnology Short Interest Overview

As of May 29, 2026, Sana Biotechnology (SANA) had a short interest of 39.33 million shares sold short, representing 18.94% of the public float. This marks a 2.23% increase in short interest since the prior report. The short interest ratio (days to cover) is 10.4, meaning it would take 10.4 days of the average trading volume of 3.62 million shares to cover all short positions.

Current Short Interest
39,329,730 shares
Previous Short Interest
38,472,644 shares
Change Vs. Previous Month
2.23%
Dollar Volume Sold Short
$129.79 million
Short Interest Ratio
10.4 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
278,290,000 shares
Short Percent of Float
18.94%
Today's Trading Volume
2,252,215 shares
Average Trading Volume
3,623,099 shares
Today's Volume Vs. Average
62%
Short Selling Sana Biotechnology?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Sana Biotechnology and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

SANA Short Interest Over Time

SANA Days to Cover Over Time

SANA Percentage of Float Shorted Over Time

Sana Biotechnology Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/202639,329,730 shares $129.79 million +2.2%18.9%10.39 $3.30
5/15/202638,472,644 shares $118.11 million -6.4%18.5%8.53 $3.07
4/30/202641,091,249 shares $135.19 million +0.5%20.4%13.16 $3.29
4/15/202640,878,901 shares $140.62 million +3.8%21.9%10.22 $3.44
3/31/202639,379,007 shares $113.41 million +5.0%21.1%12.36 $2.88
3/13/202637,516,467 shares $126.06 million +4.7%20.4%12.43 $3.36
2/27/202635,826,361 shares $150.83 million -3.9%19.5%22.64 $4.21
2/13/202637,267,638 shares $143.48 million +1.0%20.3%17.28 $3.85
1/30/202636,885,918 shares $163.40 million -0.6%20.1%14.88 $4.43
1/15/202637,111,616 shares $173.31 million +1.3%20.2%14.69 $4.67
12/31/202536,621,285 shares $149.05 million -3.0%20.0%9.86 $4.07
12/15/202537,764,342 shares $191.84 million -1.5%20.6%6.11 $5.08
11/28/202538,336,153 shares $169.64 million +15.8%20.9%8.94 $4.43
11/14/202533,118,830 shares $132.14 million +3.5%18.0%8.35 $3.99
10/31/202531,993,395 shares $158.37 million +4.5%19.5%5.28 $4.95
10/15/202530,600,000 shares $181.15 million -8.4%19.0%5.6 $5.92
9/30/202533,410,000 shares $118.61 million +15.9%23.0%6.9 $3.55
9/15/202528,830,000 shares $93.12 million -4.5%20.0%5.4 $3.23
8/31/202530,200,000 shares $92.41 million -9.5%20.9%5.5 $3.06
8/15/202533,350,000 shares $111.06 million +8.4%23.1%6 $3.33
7/31/202530,780,000 shares $124.97 million -11.7%24.4%5.6 $4.06
7/15/202534,860,000 shares $145.71 million -7.1%27.8%7.6 $4.18
6/30/202537,530,000 shares $102.46 million -13.8%29.9%8.4 $2.73
6/15/202543,560,000 shares $112.82 million -1.6%34.7%10.8 $2.59
5/31/202544,260,000 shares $95.60 million +7.1%35.3%11.7 $2.16
5/15/202541,330,000 shares $70.67 million +3.1%33.0%11.4 $1.71
4/30/202540,070,000 shares $76.13 million -1.3%31.9%12.1 $1.90
4/15/202540,610,000 shares $69.04 million +0.9%32.5%11.3 $1.70
3/31/202540,250,000 shares $67.62 million +0.9%32.2%5.2 $1.68
3/15/202539,890,000 shares $116.88 million -5.0%31.9%5.6 $2.93
2/28/202542,000,000 shares $109.62 million -5.3%33.8%6.1 $2.61
2/15/202544,330,000 shares $140.08 million -1.7%35.7%6.6 $3.16
1/31/202545,090,000 shares $145.19 million -10.3%36.8%6.8 $3.22
1/15/202550,280,000 shares $194.08 million +35.5%41.0%8.1 $3.86
12/31/202437,100,000 shares $60.47 million +0.8%30.3%7.5 $1.63
12/15/202436,820,000 shares $69.59 million +4.8%30.1%22.3 $1.89
11/30/202435,150,000 shares $97.72 million -0.6%28.8%23.3 $2.78
11/15/202435,370,000 shares $85.60 million +3.2%29.0%24.4 $2.42
10/31/202434,280,000 shares $119.98 million +3.0%28.2%25 $3.50
10/15/202433,280,000 shares $137.78 million +5.6%27.4%24.3 $4.14
The roadshow starts Monday. This stock isn't ready. (Ad)

The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the world's largest fund managers - including a section naming one small company Musk's Colossus cannot operate without. Right now, most fund managers have never heard of it. By Friday, every one of them will. Dylan Jovine has identified the name and ticker before $75 billion in new capital starts chasing the SpaceX supply chain.tc pixel

Get the stock name and ticker before the roadshow begins
9/30/202431,530,000 shares $131.16 million +1.2%25.9%20 $4.16
9/15/202431,170,000 shares $139.33 million -2.0%25.7%18.3 $4.47
8/31/202431,810,000 shares $192.45 million +0.3%26.2%18.1 $6.05
8/15/202431,710,000 shares $158.23 million +6.4%26.2%17.7 $4.99
7/31/202429,810,000 shares $181.54 million +6.9%24.7%15.8 $6.09
7/15/202427,880,000 shares $177.32 million +7.2%23.1%14.4 $6.36
6/30/202426,010,000 shares $142.01 million +6.6%21.6%14.3 $5.46
6/15/202424,410,000 shares $148.41 million -2.5%20.3%14.4 $6.08
5/31/202425,030,000 shares $187.73 million -1.8%20.9%15.7 $7.50
5/15/202425,480,000 shares $236.20 million -0.7%21.2%13.7 $9.27
4/30/202425,650,000 shares $230.85 million -4.0%20.9%12.5 $9.00
4/15/202426,720,000 shares $228.46 million +2.3%21.8%13.4 $8.55
3/31/202426,130,000 shares $261.30 million +5.9%22.2%7.9 $10.00
3/15/202424,680,000 shares $219.16 million +17.2%20.9%7.3 $8.88
2/29/202421,050,000 shares $211.34 million -4.7%17.9%6.1 $10.04
2/15/202422,080,000 shares $188.12 million +3.1%20.8%6.9 $8.52
1/31/202421,420,000 shares $117.60 million +6.2%21.5%7.2 $5.49
1/15/202420,170,000 shares $127.68 million -8.5%20.2%7.1 $6.33
12/31/202322,050,000 shares $89.96 million +3.8%22.3%13.8 $4.08
12/15/202321,240,000 shares $85.17 million +2.1%21.4%14.5 $4.01
11/30/202320,810,000 shares $84.49 million -3.7%21.1%15.4 $4.06
11/15/202321,600,000 shares $91.58 million -3.4%21.8%17.1 $4.24
10/31/202322,370,000 shares $66.22 million -13.3%22.8%19.1 $2.96
10/15/202325,800,000 shares $86.43 million +5.5%26.2%23.9 $3.35
9/30/202324,450,000 shares $94.62 million +8.4%24.9%24.5 $3.87
9/15/202322,560,000 shares $100.84 million -3.7%22.9%25 $4.47
8/31/202323,420,000 shares $125.30 million +0.6%26.7%23.9 $5.35
8/15/202323,290,000 shares $125.30 million -0.9%26.6%21.2 $5.38
7/31/202323,490,000 shares $137.65 million -14.4%27.0%18.9 $5.86
7/15/202327,430,000 shares $158.55 million -1.4%32.5%21.1 $5.78
6/30/202327,820,000 shares $165.81 million +1.3%32.9%19.5 $5.96
6/15/202327,470,000 shares $178.56 million -2.9%32.5%18.8 $6.50
5/31/202328,280,000 shares $170.25 million +0.1%33.7%20.8 $6.02
5/15/202328,240,000 shares $212.36 million +0.0%33.8%21.1 $7.52
4/30/202328,230,000 shares $149.34 million -4.5%34.3%24.1 $5.29
4/15/202329,550,000 shares $153.36 million -2.7%35.9%26.2 $5.19
3/31/202330,360,000 shares $99.28 million +1.2%37.0%30.4 $3.27
3/15/202330,010,000 shares $102.63 million +7.8%36.6%30 $3.42
2/28/202327,840,000 shares $102.17 million +3.2%34.1%28.9 $3.67
2/15/202326,980,000 shares $125.19 million +3.8%33.0%28.5 $4.64
1/31/202326,000,000 shares $118.56 million -2.1%31.7%25.7 $4.56
1/15/202326,550,000 shares $125.58 million +3.3%32.4%26 $4.73
12/30/202225,710,000 shares $101.55 million +1.7%31.3%26.2 $3.95
12/15/202225,290,000 shares $98.63 million +2.5%30.8%25.3 $3.90
11/30/202224,680,000 shares $123.15 million -1.0%30.2%23.7 $4.99
11/15/202224,930,000 shares $138.36 million -2.0%30.5%24 $5.55
10/31/202225,440,000 shares $147.55 million +0.7%30.1%22.5 $5.80
10/15/202225,270,000 shares $128.12 million -0.8%30.0%21.4 $5.07
9/30/202225,460,000 shares $152.76 million -1.7%30.2%20.5 $6.00
9/15/202225,910,000 shares $184.74 million +1.7%32.6%18.6 $7.13
How to play the Biggest IPO in stock market history! (Ad)

SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insiders and institutional holders have been sitting on positions for years and will exit the moment shares hit the market. Lance Ippolito has identified five stocks directly positioned to benefit from the SpaceX launch and the space investing wave it triggers, without the brutal IPO volatility. These picks carry none of the hype risk and all of the tailwind.tc pixel

Get all five tickers now, completely free
8/31/202225,490,000 shares $173.59 million +3.3%32.1%18 $6.81
8/15/202224,680,000 shares $208.30 million +1.9%31.0%16.3 $8.44
7/31/202224,220,000 shares $161.79 million +8.4%30.7%15 $6.68
7/15/202222,350,000 shares $170.08 million +5.7%28.3%14 $7.61
6/30/202221,150,000 shares $135.99 million +11.1%26.8%12.8 $6.43
6/15/202219,030,000 shares $82.59 million +0.5%24.1%11.5 $4.34
5/31/202218,940,000 shares $97.16 million +1.6%24.0%11.8 $5.13
5/15/202218,640,000 shares $93.95 million +3.6%23.6%12.3 $5.04
4/30/202218,000,000 shares $135.90 million +1.4%23.3%13.2 $7.55
4/15/202217,750,000 shares $148.39 million +8.0%22.9%13.2 $8.36
3/31/202216,440,000 shares $135.79 million +20.2%21.4%12.9 $8.26
3/15/202213,680,000 shares $78.52 million +1.5%17.8%12.6 $5.74
2/28/202213,480,000 shares $87.08 million +3.9%17.6%13.8 $6.46
2/15/202212,970,000 shares $92.99 million +15.4%16.9%13.7 $7.17
1/31/202211,240,000 shares $98.46 million +18.6%14.6%13 $8.76
1/15/20229,480,000 shares $107.79 million -3.2%12.4%13.5 $11.37
12/31/20219,790,000 shares $151.55 million +23.6%12.8%16.6 $15.48
12/15/20217,920,000 shares $134.72 million +7.6%10.3%13.5 $17.01
11/30/20217,360,000 shares $139.91 million -7.8%9.7%9.1 $19.01
11/15/20217,980,000 shares $171.17 million -1.9%10.5%9.1 $21.45
10/29/20218,130,000 shares $168.62 million -3.0%10.6%9 $20.74
10/15/20218,380,000 shares $174.22 million -0.4%10.9%9.1 $20.79
9/30/20218,410,000 shares $189.39 million +32.2%11.0%9.4 $22.52
9/15/20216,360,000 shares $164.60 million -2.0%8.3%6.9 $25.88
8/31/20216,490,000 shares $155.76 million +2.2%8.5%10.1 $24.00
8/13/20216,350,000 shares $129.35 million No Change8.3%13.1 $20.37

SANA Short Interest - Frequently Asked Questions

Short interest is the volume of Sana Biotechnology shares that have been sold short but have not yet been covered or closed out. As of May 29th, traders have sold 39,329,730 shares of SANA short. 18.94% of Sana Biotechnology's shares are currently sold short. Learn More on Sana Biotechnology's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SANA shares currently have a short interest ratio of 10.4. Learn More on Sana Biotechnology's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 18.94% of Sana Biotechnology's floating shares are currently sold short.

Sana Biotechnology saw a increase in short interest in May. As of May 29th, there was short interest totaling 39,329,730 shares, an increase of 2.2% from the previous total of 38,472,644 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

18.94% of Sana Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Sana Biotechnology: Tango Therapeutics, Inc. (24.76%), Arcus Biosciences, Inc. (10.30%), Dyne Therapeutics, Inc. (14.88%), Adaptive Biotechnologies Corporation (5.46%), Structure Therapeutics Inc. Sponsored ADR (8.30%), Arcutis Biotherapeutics, Inc. (14.32%), Relay Therapeutics, Inc. (18.90%), Disc Medicine, Inc. (16.33%), Kailera Therapeutics, Inc. (2.07%), Tarsus Pharmaceuticals, Inc. (13.19%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling SANA is an investing strategy that aims to generate trading profit from Sana Biotechnology as its price is falling. SANA shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Sana Biotechnology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SANA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SANA, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like SANA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



This page (NASDAQ:SANA) was last updated on 6/14/2026 by MarketBeat.com Staff.
From Our Partners